LiteCure, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
LiteCure, LLC - overview
Established
2006
Location
New Castle, DE, US
Primary Industry
Medical Devices & Equipment
About
LiteCure, LLC develops advanced laser therapy technologies that enhance healing and pain relief for both human and veterinary applications, providing innovative solutions for recovery and rehabilitation. LiteCure, LLC, founded in 2006, is based in New Castle, US, and specializes in laser therapy technologies. The company's journey includes a strategic acquisition by DJO Global Inc. in December 2020, enhancing its operational capabilities.
Brian Pryor serves as CEO. LiteCure specializes in advanced laser therapy technologies designed to enhance healing and pain relief across various markets. Their primary offerings include the LightForce Deep Tissue Laser Therapy system, engineered to reduce recovery times for patients. The company also provides Companion Therapy solutions tailored for veterinary professionals, focusing on healing and improving the quality of life for animals.
Additionally, the Pegasus Therapy Lasers deliver drug-free and surgery-free pain relief for equine athletes. LiteCure's products are distributed globally, serving veterinary clinics, sports medicine professionals, and rehabilitation centers in North America, Europe, and select markets in Asia. LiteCure's revenue model primarily revolves around direct sales of laser therapy products to healthcare and veterinary professionals, through both direct-to-consumer channels and business-to-business relationships. Partnerships with distributors broaden its reach in international markets, with flagship products like the LightForce Deep Tissue Laser Therapy and Pegasus Therapy Lasers forming the core of their revenue-generating portfolio.
LiteCure aims to continue expanding its product line, including the development of new laser therapy solutions for both human and veterinary markets. The company plans to target expansion into additional regions, particularly focusing on Europe and Asia by 2025. The acquisition by DJO Global Inc. will provide the necessary resources to support these initiatives, ensuring that LiteCure can enhance its market presence post-acquisition.
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Therapeutic Devices
Website
www.litecure.com
Verticals
Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
LiteCure, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | LiteCure, LLC | - | ||||||||
| Growth | Completed | LiteCure, LLC | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.